Göran Smedegård
Director/Miembro de la Junta en Axcentua Pharmaceuticals AB .
Cargos activos de Göran Smedegård
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
Axcentua Pharmaceuticals AB
 Axcentua Pharmaceuticals AB Pharmaceuticals: MajorHealth Technology Axcentua Pharmaceuticals AB develops anti-cancer drugs for pancreatic cancer patients. It generates investigational new drugs for diseases with unmet medical need in Sweden. The firm offers AXP107-11, multi-targeted chemosensitizer and a small-molecule anti-cancer compound for the treatment of various solid tumors, such as non-small cell lung cancers. The company was founded in 2007 by Anders Berkenstam, Stefan Rehnmark and Michael-Robin Witt and is headquartered in Stockholm, Sweden. | Director/Miembro de la Junta | 17/09/2009 | - |
Historial de carrera de Göran Smedegård
Antiguos cargos conocidos de Göran Smedegård.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| Pharmacia AB | Corporate Officer/Principal | - | 15/01/2009 |
AstraZeneca AB
 AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Corporate Officer/Principal | - | - |
Innoventus Project AB
 Innoventus Project AB Miscellaneous Commercial ServicesCommercial Services Innoventus Project AB engages in the development and commercialization of ideas, projects, and patents in life science. The company was founded on October 6, 2001 and is headquartered in Uppsala, Sweden. | Director de Inversiones | 17/09/2009 | - |
| Fundador | 17/09/2009 | - | |
| OREXO AB | Corporate Officer/Principal | - | - |
Estadísticas
Internacional
| Suecia | 6 |
Operativa
| Corporate Officer/Principal | 3 |
| Director/Board Member | 1 |
| Chief Investment Officer | 1 |
Sectorial
| Health Technology | 4 |
| Commercial Services | 3 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| OREXO AB | Health Technology |
| Empresas privadas | 4 |
|---|---|
Axcentua Pharmaceuticals AB
Axcentua Pharmaceuticals AB Pharmaceuticals: MajorHealth Technology Axcentua Pharmaceuticals AB develops anti-cancer drugs for pancreatic cancer patients. It generates investigational new drugs for diseases with unmet medical need in Sweden. The firm offers AXP107-11, multi-targeted chemosensitizer and a small-molecule anti-cancer compound for the treatment of various solid tumors, such as non-small cell lung cancers. The company was founded in 2007 by Anders Berkenstam, Stefan Rehnmark and Michael-Robin Witt and is headquartered in Stockholm, Sweden. | Health Technology |
Innoventus Project AB
Innoventus Project AB Miscellaneous Commercial ServicesCommercial Services Innoventus Project AB engages in the development and commercialization of ideas, projects, and patents in life science. The company was founded on October 6, 2001 and is headquartered in Uppsala, Sweden. | Commercial Services |
| Pharmacia AB | Health Technology |
AstraZeneca AB
AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Commercial Services |
- Bolsa de valores
- Insiders
- Göran Smedegård
- Experiencia
